Home Business Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

by admin

Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company’s direct-to-consumer pharmacy and GoodRx, among other platforms.Original Article

You may also like

Leave a Comment

sixteen + 11 =